Quality of life of people who inject drugs: characteristics and comparisons with other population samples
To assess the quality of life (QOL) of persons who inject drugs.
Some 483 current injecting drug users visiting a large NSP over a 2-week period in October 2009 were interviewed using a structured questionnaire. QOL was measured using the WHOQOL-BREF. Data were collected on age, gender, injecting patterns, current drug treatment status and hepatitis C status. Participant QOL profiles were compared to published domain scores for a range of other population groups.
People who inject drugs (PWID) experience a very poor QOL irrespective of socio-demographic characteristics, injecting patterns, hepatitis C sero-status and drug treatment status. Sample participants (PWID) experience a QOL below that experienced by many population groups in the community affected by disabling chronic illnesses.
Injecting drug use is associated with a poor QOL. Some PWID may be self-medicating for chronic non-malignant pain, and it is likely that these people had a low QOL prior to the decision to inject. Despite this caveat, it remains likely that injecting drug use does little to enhance the QOL of the user.
KeywordsPeople who inject drugs Quality of life Needle and syringe programme
- 5.Reference Group to the United Nations on HIV and Injecting Drug Use. (2010). Consensus statement of the Reference Group to the United Nations on HIV and Injecting Drug Use 2010: Summary of Recommendations.Google Scholar
- 7.Australian Institute of Health and Welfare. (2011). 2010 National Drug Strategy Household Survey Report, Australian Institute of Health and Welfare: Canberra.Google Scholar
- 10.Sepehrmanesh, Z., & Ahmadvand, A. (2009). Psychopathology of injecting abuser. American Journal of Addictions, 4, 332–333.Google Scholar
- 12.Lemstra, M., Rogers, M., Thompson, A., Moraros, J., & Buckingham, R. (2011). Risk indicators of depressive symptomatology among injection drug users and increased HIV risk behaviour. Canadian Journal of Psychiatry, 56, 358–366.Google Scholar
- 14.Rooney, S., Freyne, A., Kelly, G., & O’Connor, J. (2007). Differences in the quality of life of two groups of drug users. International Journal Psychiatry Medicine, 19, 55–59.Google Scholar
- 17.de Wit, J., Treloar, C., & Wilson, H., (eds). (2009). HIV/AIDS, hepatitis and sexually transmissilbe infections in Australia: Annual report of trends in behaviour 2009. National Centre in HIV Social Research, The University of New South Wales: Sydney.Google Scholar
- 18.National Centre for HIV Epidemiology and Clinical Research. (2010). Australian NSP survey national data report 2005–2009. Sydney: National Centre for HIV Epidemiology and Clinical Research, The University of New South Wales.Google Scholar
- 20.Skevington, S. M., Lofty, M., & O’Connell, K. A. (2004). The World Health Organization’s WHOQOL-BREF: preliminary population norms and effect sizes. Social Indicators Research, 13, 299–310.Google Scholar
- 23.Murphy, B., Herman, H., Hawthorne, G., Pinzone, T., & Evert, H. T. (2000). The World Health Organization Quality of Life (WHOQOL) Study: Australian WHOQOL-100, WHOQOL-BREF, and CA-WHOQOL instruments—User’s manual and interpretation guide. Melbourne: WHO-QOL Field Study Centre, University of Melbourne.Google Scholar
- 24.Skevington, S. M., McCrate, F. M. (2012). Expecting a good quality of life in health: Assessing people with diverse diseases and conditions using the WHOQOL-BREF. Health Expectations, 49–62.Google Scholar
- 30.Aigner, M., Forster-Streffleur, S., Prause, W., Friedl, M., Weiss, M., et al. (2006). What does WHOQOL-BREF measure? Measurement overlap between quality of life and depressive symptomology in chronic somatoform pain disorder. Social Psychiatry and Psychiatry Epidemiology, 41, 81–86.CrossRefGoogle Scholar
- 31.StataCorp. (2009). Stata statistical software. College Station, TX: StataCorp LP.Google Scholar
- 34.Connor, J., Saunders, J., & Feeney, G. (2006). Quality of life in substance use disorders. In H. Katschnig, H. Freeman, & N. Sartorius (Eds.), Quality of life in mental disorders. Hoboken, NJ: Wiley.Google Scholar